🔎 Trials Near Me

Inicio › Cáncer de pulmón › South Carolina

Ensayos clínicos de Cáncer de pulmón en South Carolina

19 estudios sobre Cáncer de pulmón buscan participantes en South Carolina.

Ciudades en South Carolina

Texto oficial del estudio (inglés)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Ralph H Johnson VA Medical Center, Charleston
  • Medical University of South Carolina, Charleston
ReclutandoFase 3
Edades de 70 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • Bon Secours Saint Francis Hospital, Charleston
  • y 15 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AnMed Health Cancer Center, Anderson
  • Prisma Health Richland Hospital, Columbia
  • McLeod Regional Medical Center, Florence
  • y 12 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • Prisma Health Cancer Institute - Easley, Easley
  • Gibbs Cancer Center-Gaffney, Gaffney
  • y 9 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06498635

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Saint Joseph's Candler Health System ( Site 4010), Bluffton
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06312137

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Medical University of South Carolina, Florence
  • Medical University of South Carolina Health Lancaster Medical Center, Lancaster
ReclutandoFase 3
Edades de 18 a 100 · Todos los sexos · Actualizado el 25 sept 2026 · NCT05920356

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Medical University of South Carolina, Charleston
  • Prisma Health Cancer Institute, Greenville
  • Lexington Medical Center, West Columbia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06119581

Health Education Approach to Lung Screening

  • Medical University of South Carolina, Charleston
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 80 · Todos los sexos · Actualizado el 25 ago 2026 · NCT06070870

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Gibbs Cancer Center-Gaffney, Gaffney
  • Saint Francis Hospital, Greenville
  • y 8 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996

Prediction Augmented Screening Initiative

  • Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Reclutando
Edades de 50 a 80 · Todos los sexos · Actualizado el 26 jun 2026 · NCT06538636

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • AnMed Health Cancer Center, Anderson
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • y 9 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • AnMed Health Cancer Center, Anderson
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Medical University of South Carolina, Charleston
  • y 5 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • AnMed Health Cancer Center, Anderson
ReclutandoFase 2
18 Minutes · Todos los sexos · Actualizado el 5 may 2026 · NCT06031688

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Medical University of South Carolina, Charleston
  • McLeod Health, Florence
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 en adelante · Todos los sexos · Actualizado el 20 ene 2026 · NCT05366881

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • AnMed Health Cancer Center, Anderson
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Gibbs Cancer Center-Gaffney, Gaffney
  • y 7 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 ene 2026 · NCT06073431

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Greenville
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Medical University of South Carolina (MUSC), Charleston
  • McLeod Health, Florence
ReclutandoEstudio observacional
Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

  • Ralph H. Johnson VA Health Care System, Charleston
ReclutandoEstudio observacional
Edades de 29 a 85 · Todos los sexos · Actualizado el 13 nov 2024 · NCT06426628

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.